Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
MITSUI-SOKO HOLDINGS, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 17%, Oct-Dec Ordinary Profit Increases by 10%
9302 MITSUI-SOKO HOLDINGS Co., Ltd. 【J-GAAP】
Earnings ReportMITSUI-SOKO HOLDINGS Co., Ltd. <9302> [TSE Prime] announced its financial results after the market closed on February 6th (17:00). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending March 2026 (April to December) increased 16.9% from the same period last year, reaching 17.6 billion yen. Progress toward the full-year plan of 20.5 billion yen was 86.1%, also surpassing the five-year average of 79.9%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the January to March period (4Q) is expected to decrease 2.8% from the same period last year to 2.85 billion yen.
In the most recent three-month period, from October to December (3Q), the consolidated ordinary profit grew 9.8% from the same period last year, reaching 6.14 billion yen. The operating profit margin improved from 7.5% in the same period last year to 8.0%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Dec, 2023 | 197,464 | 16,895 | 17,436 | 9,975 | 133.6 | 83.0 | Feb 7, 2024 | J-GAAP |
| Apr - Dec, 2024 | 212,004 | 14,925 | 15,102 | 8,961 | 119.8 | 83.7 | Feb 6, 2025 | J-GAAP |
| Apr - Dec, 2025 | 225,839 | 17,967 | 17,647 | 9,036 | 120.8 | 86.1 | Feb 6, 2026 | J-GAAP |
| YoY | +6.5% | +20.4% | +16.9% | +0.8% | +0.8% |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2024 | 142,070 | 8,372 | 8,533 | 4,193 | 56.1 | 24.34 | May 9, 2025 | J-GAAP |
| Oct - Mar, 2025 Guidance | 146,991 | 9,872 | 8,999 | 4,911 | 65.6 | 24.50 | Nov 7, 2025 | J-GAAP |
| YoY | +3.5% | +17.9% | +5.5% | +17.1% | +17.0% |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Mar, 2024 | 260,593 | 20,754 | 21,010 | 12,107 | 162.1 | 48.67 | May 10, 2024 | J-GAAP |
| Mar, 2025 | 280,742 | 17,831 | 18,037 | 10,040 | 134.3 | 48.67 | May 9, 2025 | J-GAAP |
| Mar, 2026 Guidance | 294,000 | 21,500 | 20,500 | 10,500 | 140.3 | 49 | Nov 7, 2025 | J-GAAP |
| YoY | +4.7% | +20.6% | +13.7% | +4.6% | +4.5% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Dec, 2024 | 73,332 | 5,466 | 5,598 | 3,114 | 41.6 | 7.5 | Feb 6, 2025 | J-GAAP |
| Jan - Mar, 2025 | 68,738 | 2,906 | 2,935 | 1,079 | 14.4 | 4.2 | May 9, 2025 | J-GAAP |
| Apr - Jun, 2025 | 73,624 | 6,385 | 6,529 | 3,272 | 43.7 | 8.7 | Aug 4, 2025 | J-GAAP |
| Jul - Sep, 2025 | 73,385 | 5,243 | 4,972 | 2,317 | 31.0 | 7.1 | Nov 7, 2025 | J-GAAP |
| Oct - Dec, 2025 | 78,830 | 6,339 | 6,146 | 3,447 | 46.1 | 8.0 | Feb 6, 2026 | J-GAAP |
| YoY | +7.5% | +16.0% | +9.8% | +10.7% | +10.6% |
Related Articles
SHIN NIPPON BIOMEDICAL, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 10%
Nikkei 225 close on the 6th = rebound for the first time in 3 days, 435 yen higher to 54,253 yen
KAINOS Laboratories, Postponed Dividend for This Fiscal Year
Cookpad, 44% Decrease in Net Income for the Last Fiscal Year, Current period performance is undisclosed.
SUMIDA, 1% Increase in Net Income for The Current Fiscal Year
Alue, Ordinary Profit Forecast for Last Fiscal Year Revised Upward by 38%, Highest in Four Terms
FUJITEC, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 26%, Oct-Dec Ordinary Profit Increases by 39%
OncoTherapy Science, Apr-Dec (Cumulative 3Q) Net Income Loss Widens, Oct-Dec Net Income Loss Widens
IPS, First Half Ordinary Profit Increases by 28%
TOYO ELECTRIC, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 1%